The dosing schedule can be adjusted if needed
Ozempic and Mounjaro are FDA-approved for the management of type 2 diabetes (with Ozempic also approved to reduce cardiovascular risk in T2D patients), but both are sometimes prescribed off-label at a providers discretion
Daniel McGee, Board-certified Family Medicine Physician Put simply, they need to know about your health habits so they can do their jobs
Explore our medical weight loss programs to learn more
Reduced Risk of Obesity-Related Conditions Achieving and maintaining a healthier weight with Semaglutide may lower the risk of conditions such as heart disease, stroke, sleep apnea, and certain types of cancer
Both Ozempic and Wegovy have experienced supply constraints, making compounded versions legally available under federal compounding regulations